Macquarie sees 67% upside in PB Fintech despite insurance commission-rule risk
Macquarie has retained its Outperform rating and Rs 1,950 target for PB Fintech, implying 67.41% upside. The broker expects limited impact in FY27 from draft insurance commission rules, recalibration in FY28 and a return to the company’s prior growth trajectory by FY29.
The development
Macquarie retained an Outperform rating and Rs 1,950 target for PB Fintech, implying 67.41 per cent upside. It expects limited FY27 impact from draft commission rules, FY28 recalibration and a return to PB Fintech's earlier trajectory by FY29.
The numbers
- Rs 1,950
- 67.41 per cent
- FY27
- FY28
- FY29
Why it matters to operators and investors
Macquarie’s retained Outperform rating and Rs 1,950 target frame PB Fintech as a high-upside opportunity, though draft commission rules remain a near-term earnings-risk catalyst.
What to watch next
- Final insurance commission regulations, implementation date, commission caps and treatment of service or performance-linked payments.
- Management commentary on FY27 insurance revenue growth, take rate, new-premium growth and adjusted EBITDA margin.
- Insurer responses: product repricing, channel payout changes, direct-to-consumer investment and policy mix shifts.
- Policybazaar market-share trends versus agents, banks, insurer-owned platforms and other aggregators.
- Renewal rates, customer acquisition cost, agent productivity and health-insurance contribution to premiums.
The counter-case
The 67% upside case depends on FY27 commission-rule impact being contained, FY28 recalibration being smooth, and growth normalizing by FY29. Those assumptions may be optimistic: insurers could cut payouts more aggressively, shift products or distribution economics, and force PB Fintech to spend more on customer acquisition or accept lower take rates. Regulatory uncertainty can also compress valuation multiples well before earnings effects are visible.